Cavendish says FDA alignment de-risks Poolbeg Pharma's lead cancer therapy programme for partners

Shares Poolbeg Pharma PLC (AIM:POLB, OTC:POLBF, FRA:POLBF), the clinical-stage biopharmaceutical company, were up 9% following the positive outcome of a...